| Literature DB >> 35843938 |
Bernard Bhakkan-Mambir1,2, Jacqueline Deloumeaux3, Danièle Luce4.
Abstract
BACKGROUND: Geographical disparities in cancer incidence are observed at different scales and may highlight areas of high risk that need special attention to improve health policies. In Guadeloupe, a French archipelago in the Caribbean, environmental and socioeconomic factors are potential factors associated with cancer incidence. Our objective was to describe geographical variations of cancer incidence in Guadeloupe at a small-area level, in order to identify potential clusters.Entities:
Keywords: Caribbean; Spatial analysis; cancer; incidence
Mesh:
Year: 2022 PMID: 35843938 PMCID: PMC9290250 DOI: 10.1186/s12885-022-09886-6
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.638
Age-standardized incidence rates (World) per 100,000 in 2020, both sexes
| Guadeloupe | USA | Caribbean | France | |
|---|---|---|---|---|
| Breast | 67.9 | 90.3 | 50.9 | 99.1 |
| Cervix Uteri | 7.9 | 6.2 | 13.7 | 7.0 |
| Corpus Uteri | 9.7 | 21.4 | 12.7 | 14.9 |
| Ovary | 8.3 | 8.1 | 4.6 | 6.9 |
| Prostate | 183.6 | 72.0 | 75.8 | 99.0 |
| Stomach | 10.7 | 7.9 | 6.9 | 4.7 |
| Liver | 4.0 | 6.9 | 5.5 | 7.6 |
| Colon-rectum | 21.9 | 25.6 | 18.2 | 30.1 |
| Esophagus | 2.9 | 2.8 | 2.8 | 3.6 |
| Pancreas | 8.3 | 8.2 | 4.3 | 8.6 |
| Lung | 11.3 | 33.1 | 17.6 | 34.9 |
| Brain | 2.7 | 5.4 | 3.3 | 6.7 |
| Thyroid | 4.5 | 11.8 | 3.9 | 14.8 |
| Head and neck | 8.6 | 10.3 | 10.0 | 16.3 |
| Multiple myeloma | 5.0 | 4.9 | 2.3 | 4.2 |
| Melanoma | 1.5 | 16.6 | 0.7 | 15.2 |
| Kidney | 2.5 | 12.4 | 2.7 | 11.2 |
| All cancers | 258.6 | 362.2 | 191.7 | 341.9 |
Data were extracted from the Globocan 2020 database [1]
Fig. 1Smoothed SIRs for head and neck and digestive cancers. a Head and neck cancer. b Esophageal cancer. c- Stomach cancer. d Colon cancer. e Rectal cancer. f Liver cancer. g Pancreatic cancer
Fig. 2Smoothed SIRs for urogenital cancers. a Breast cancer. b Cervical cancer. c Uterine corpus cancer. d Ovary cancer. e Prostate cancer
Fig. 3Smoothed SIRs for other cancers. a Lung cancer. b Brain cancer. c Thyroid cancer. d Melanoma. e Multiple myeloma
Fig. 4Dendrogram showing the relationships between the smoothed SIRs of the 18 cancer sites
Fig. 5Spearman’s correlation coefficients between the smoothed SIRs
Fig. 6Clustering of the IRIS based on smoothed SIRs of different cancers
Average smoothed SIRs by cancer site for each cluster
| Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | Cluster 6 | |
|---|---|---|---|---|---|---|
| Breast | 0.95 | 1.00 | 1.11 | 0.97 | 0.66 | 1.30 |
| Cervix uteri | 0.97 | 0.98 | 1.36 | 0.91 | 0.29 | 0.68 |
| Corpus uteri | 0.70 | 0.97 | 1.02 | 1.12 | 1.12 | 0.41 |
| Ovary | 0.67 | 0.92 | 1.13 | 1.22 | 0.88 | 0.00 |
| Prostate | 0.96 | 1.05 | 1.08 | 0.93 | 1.26 | 0.71 |
| Stomach | 1.20 | 0.98 | 0.93 | 1.02 | 1.02 | 0.75 |
| Liver | 0.60 | 1.17 | 1.08 | 0.66 | 1.76 | 0.00 |
| Colon | 0.89 | 1.04 | 1.15 | 0.87 | 1.20 | 0.63 |
| Esophagus | 1.07 | 0.91 | 0.94 | 1.01 | 2.53 | 0.00 |
| Rectum | 0.98 | 1.04 | 1.10 | 0.84 | 1.30 | 0.41 |
| Pancreas | 0.93 | 0.98 | 1.05 | 1.02 | 0.85 | 1.17 |
| Lung | 0.85 | 1.03 | 1.09 | 0.90 | 1.22 | 0.66 |
| Brain | 0.71 | 1.13 | 1.13 | 0.76 | 0.86 | 1.16 |
| Thyroid | 1.27 | 0.95 | 0.99 | 1.12 | 0.31 | 0.68 |
| Head and neck | 0.91 | 0.95 | 1.25 | 0.91 | 1.63 | 0.64 |
| Multiple myeloma | 0.92 | 1.04 | 1.13 | 0.98 | 0.54 | 0.34 |
| Melanoma | 0.92 | 0.83 | 0.90 | 1.29 | 0.71 | 4.48 |
| Kidney | 0.74 | 1.00 | 0.90 | 1.15 | 1.14 | 0.06 |